IPO-bound PharmEasy signs up Bollywood actor Aamir Khan as brand ambassador

IPO-bound e-pharmacy model and healthcare app Pharmeasy has introduced the appointment of Bollywood actor Aamir Khan as its model ambassador. The partnership will embrace endorsement throughout mediums, together with TV commercials that includes Aamir Khan as a part of IPL 2022.

“It is indeed a pleasure to work together with the PharmEasy brand, to help provide economical healthcare at each person’s doorstep. I feel that in today’s times, PharmEasy is providing an essential service, in a sector that is itself a fundamental requirement for all of us, and I look forward to this association,” mentioned Aamir Khan in an announcement issued by the corporate.

As the face of the model, Aamir Khan will promote the benefit of availability of medicines, diagnostic checks and healthcare merchandise on the PharmEasy app. Collaborating with Aamir Khan will additional strengthen the model’s perception in making healthcare accessible to each nook and nook of the nation, mentioned an announcement issued by the corporate.

“Collaborating with someone as versatile as Aamir Khan fills us with immense joy. We are absolutely thrilled to have him on board as the face of the brand PharmEasy. He truly knows how to engage with the audience,” mentioned Gaurav Verma, CMOT at API Holdings, the father or mother firm of PharmEasy model.

He additional added, “With this association, we aim to reach more people while making affordable healthcare accessible to everyone. We are looking forward to a great collaboration with him this year and widening our reach through offerings and such campaigns.”

API Holdings filed the Draft Red Herring Prospectus (DRHP) in November 2021 to boost Rs 6,250 crore by an preliminary public providing by major share sale. The firm is in dialog with bankers to boost Rs 1,250 crore by a pre-IPO spherical which is able to deliver down the recent situation measurement. Recent media studies, nevertheless, level at a delay within the firm’s plan to listing publicly. 

The firm has additionally earmarked Rs 1,500 crore in direction of inorganic development and strategic investments. 

Source hyperlink

Leave a Reply

Your email address will not be published.